THE SWATCH GROUP (ITALIA) SPA

QIAGEN Expands QIAcuity Digital PCR Ecosystem with New Gene Expression Assays, High-Multiplex Capabilities, and Workflow Automation

- QIAGEN announced new additions to its QIAcuity digital PCR ecosystem, including planned gene expression assays for human, mouse, and rat research applications launching later in 2026. - The new QIAcuity OneStep High Multiplex Probe PCR Kit will enable analysis of up to 12 RNA targets in a single reaction, reducing sample consumption and workflow complexity. - QIAcuity Software 3.5, scheduled for release later this month, introduces automated analysis templates and reporting to standardize data interpretation in regulated workflows. - QIAGEN is expanding its Cell and Gene Therapy quality control portfolio with residual DNA testing support for additional producer cell systems including Sf9/Baculovirus, Pichia pastoris, Vero, and Mouse.